阿育吠陀草药产品中的重金属含量
Robert B Saper1, Stefanos N Kales, Janet Paquin
1Division for Research and Education in Complementary and Integrative Medical Therapies, Osher Institute, Harvard Medical School, Boston, USA. robert.saper@bmc.org
在波士顿销售的阿育吠陀草药产品 (HMP) 中,有20%含有有毒的重金属,如,和. 这些产品可能存在重金属毒性风险,需要强制性测试.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿育吠陀草药产品 (HMP) 与,和中毒有关.
- 有关在南亚制造的HMP的安全性存在担忧.
研究的目的:
- 评估在波士顿销售的南亚阿育吠陀HMP中重金属的流行率和度.
- 将这些产品估计的每日金属摄入量与既定监管标准进行比较.
主要方法:
- 一次系统的搜索确定了在波士顿20英里半径内销售南亚HMP的商店.
- 在2003年4月至10月期间,从确定的商店购买了阿育吠陀HMP.
- 使用X射线光光谱测量重金属度 (,,).
主要成果:
- 70个阿育吠陀医疗保健药物中的14个 (20%) 含有,和/或.
- 检测到的度中位数为的40μg/g,的20,225μg/g,的430μg/g.
- 从这些产品中估计每天摄入的重金属超过了监管标准,如果按照指示使用.
结论:
- 波士顿商店中可获得的南亚阿育吠陀HMP的很大一部分含有潜在的有害水平的有毒重金属.
- 使用这些产品的消费者可能面临重金属毒性的风险.
- 建议对阿育吠陀医疗保健医师进行有毒重金属的强制性测试,以确保产品的安全性.
更多相关视频
10:20Quantification of Heavy Metals and Other Inorganic Contaminants on the Productivity of Microalgae
Published on: July 10, 2015
10:31Detection and Recovery of Palladium, Gold and Cobalt Metals from the Urban Mine Using Novel Sensors/Adsorbents Designated with Nanoscale Wagon-wheel-shaped Pores
Published on: December 6, 2015
相关概念视频
The Periodic Table and Organismal Elements
The Periodic Table and Organismal Elements
Periodic Table Provides Information...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiovascular Drugs: Classification based on Therapeutic Indications
